Waldo Mattos

986 total citations
14 papers, 534 citations indexed

About

Waldo Mattos is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Waldo Mattos has authored 14 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 5 papers in Physiology and 3 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Waldo Mattos's work include Asthma and respiratory diseases (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). Waldo Mattos is often cited by papers focused on Asthma and respiratory diseases (4 papers), Cardiac, Anesthesia and Surgical Outcomes (3 papers) and Cardiac Valve Diseases and Treatments (2 papers). Waldo Mattos collaborates with scholars based in Brazil, United Kingdom and Germany. Waldo Mattos's co-authors include Peter J. Barnes, Sam Lim, Kian Fan Chung, Brian G. Oliver, Nicolás Roche, Anon Jatakanon, Richard Russell, David A. Groneberg, Axel Fischer and Gaetano Caramori and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and CHEST Journal.

In The Last Decade

Waldo Mattos

13 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waldo Mattos Brazil 8 306 223 94 66 52 14 534
Amir Bar‐Shai Israel 11 180 0.6× 77 0.3× 99 1.1× 57 0.9× 22 0.4× 56 443
Angelantonio Maglio Italy 15 230 0.8× 298 1.3× 85 0.9× 129 2.0× 22 0.4× 38 682
Amanda Iglesias Spain 15 452 1.5× 276 1.2× 148 1.6× 116 1.8× 32 0.6× 40 760
Toshihiko Hino Japan 7 358 1.2× 221 1.0× 60 0.6× 59 0.9× 34 0.7× 12 530
Baosen Pang China 12 190 0.6× 57 0.3× 94 1.0× 48 0.7× 66 1.3× 59 383
Akihiko Taniguchi Japan 14 303 1.0× 176 0.8× 98 1.0× 115 1.7× 17 0.3× 45 541
Fan Wu China 11 244 0.8× 138 0.6× 67 0.7× 21 0.3× 14 0.3× 57 408
Monica Goldklang United States 11 189 0.6× 109 0.5× 107 1.1× 111 1.7× 46 0.9× 30 477
Maria V. Tahamont United States 14 133 0.4× 34 0.2× 60 0.6× 76 1.2× 34 0.7× 28 440
Tomoyuki Soma Japan 13 245 0.8× 290 1.3× 101 1.1× 102 1.5× 5 0.1× 46 559

Countries citing papers authored by Waldo Mattos

Since Specialization
Citations

This map shows the geographic impact of Waldo Mattos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waldo Mattos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waldo Mattos more than expected).

Fields of papers citing papers by Waldo Mattos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waldo Mattos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waldo Mattos. The network helps show where Waldo Mattos may publish in the future.

Co-authorship network of co-authors of Waldo Mattos

This figure shows the co-authorship network connecting the top 25 collaborators of Waldo Mattos. A scholar is included among the top collaborators of Waldo Mattos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waldo Mattos. Waldo Mattos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Mattos, Waldo, Nasreen Khalil, Lisa Spencer, et al.. (2024). Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 210(4). 435–443. 10 indexed citations
2.
Mattos, Waldo, et al.. (2020). Is Pulmonary Auscultation Alone Sufficient for Clinical Practice?. 10(3). 49–58.
3.
Schaan, Camila Wohlgemuth, et al.. (2010). Incidência de complicações pulmonares na cirurgia de revascularização do miocárdio. SHILAP Revista de lepidopterología. 5 indexed citations
4.
Schaan, Camila Wohlgemuth, et al.. (2010). Incidência de complicações pulmonares na cirurgia de revascularização do miocárdio. Arquivos Brasileiros de Cardiologia. 95(4). 441–447. 11 indexed citations
5.
Leguisamo, Camila Pereira, et al.. (2009). Perfil ventilatório dos pacientes submetidos a cirurgia de revascularização do miocárdio. Brazilian Journal of Cardiovascular Surgery. 24(2). 180–187. 48 indexed citations
6.
Mattos, Waldo, et al.. (2009). Acurácia do exame clínico no diagnóstico da DPOC. Jornal Brasileiro de Pneumologia. 35(5). 404–408. 9 indexed citations
7.
Rubio, Fernando Gôngora, Clóvis Arns da Cunha, Fernando Luiz Cavalcanti Lundgren, et al.. (2008). Intravenous azithromycin plus ceftriaxone followed by oral azithromycin for the treatment of inpatients with community-acquired pneumonia: an open-label, non-comparative multicenter trial. The Brazilian Journal of Infectious Diseases. 12(3). 202–209. 4 indexed citations
8.
Mattos, Waldo, et al.. (2008). Exame do escarro no manejo clínico dos pacientes com pneumonia adquirida na comunidade. Jornal Brasileiro de Pneumologia. 34(3). 152–158. 12 indexed citations
9.
10.
11.
12.
Mattos, Waldo, Sam Lim, Richard Russell, et al.. (2002). Matrix Metalloproteinase-9 Expression in Asthma. CHEST Journal. 122(5). 1543–1552. 145 indexed citations
13.
Lim, Sam, David A. Groneberg, Axel Fischer, et al.. (2000). Expression of Heme Oxygenase Isoenzymes 1 and 2 in Normal and Asthmatic Airways. American Journal of Respiratory and Critical Care Medicine. 162(5). 1912–1918. 89 indexed citations
14.
Lim, Sam, et al.. (2000). Balance of Matrix Metalloprotease-9 and Tissue Inhibitor of Metalloprotease-1 from Alveolar Macrophages in Cigarette Smokers. American Journal of Respiratory and Critical Care Medicine. 162(4). 1355–1360. 188 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amir Bar‐Shai Breakdown of academic impact, for papers by Angelantonio Maglio Breakdown of academic impact, for papers by Amanda Iglesias Breakdown of academic impact, for papers by Toshihiko Hino Breakdown of academic impact, for papers by Baosen Pang Breakdown of academic impact, for papers by Akihiko Taniguchi Breakdown of academic impact, for papers by Fan Wu Breakdown of academic impact, for papers by Monica Goldklang Breakdown of academic impact, for papers by Maria V. Tahamont Breakdown of academic impact, for papers by Tomoyuki Soma
Rankless by CCL
2026